Experimental approach to the gene therapy of motor neuron disease with the use of genes hypoxia-inducible factors

Controversies and priorities in amyotrophic lateral sclerosis

(2013) Martin R Turner et al.   LANCET NEUROLOGY

The genetics and neuropathology of amyotrophic lateral sclerosis

(2012) Ammar Al-Chalabi et al.   ACTA NEUROPATHOLOGICA

SOD1, ANG, TARDBP and FUS mutations in amyotrophic lateral sclerosis: A United States clinical testing lab experience

(2012) Jeffrey A. Brown et al.   Amyotrophic Lateral Sclerosis

Therapeutic Potential of N-Acetyl-Glucagon-Like Peptide-1 in Primary Motor Neuron Cultures Derived From Non-Transgenic and SOD1-G93A ALS Mice

(2012) Hui Sun et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Amyotrophic lateral sclerosis

(2011) Mamede de Carvalho et al.   CURRENT OPINION IN NEUROLOGY

Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

(2011) Peter M. Andersen et al.   Nature Reviews Neurology

Angiogenin Levels and ANG Genotypes: Dysregulation in Amyotrophic Lateral Sclerosis

(2010) Russell Lewis McLaughlin et al.   PLoS One

Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration

(2009) J. Simon Lunn et al.   Developmental Neurobiology

Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis

(2009) Rubén Fernández-Santiago et al.   JOURNAL OF NEUROLOGY

Control of Motoneuron Survival by Angiogenin

(2008) D. Kieran et al.   JOURNAL OF NEUROSCIENCE

Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS

(2008) B TURNER et al.   PROGRESS IN NEUROBIOLOGY

A novel Angiogenin gene mutation in a sporadic patient with amyotrophic lateral sclerosis from southern Italy

(2007) F.L. Conforti et al.   NEUROMUSCULAR DISORDERS